Scientists test drug mix safety for advanced prostate cancer
NCT ID NCT02592317
Summary
This study aims to understand how a prostate cancer drug called JNJ-56021927 affects the way the body processes other common medications. It involves 23 men with advanced prostate cancer that no longer responds to standard hormone therapy. Researchers are measuring drug levels in the blood to see if the cancer drug changes how other drugs work, which is important for future safe prescribing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Chisinau, Moldova
-
Study site
Barcelona, Spain
-
Study site
Seville, Spain
Conditions
Explore the condition pages connected to this study.